credit rating of the Company. Cash flow statements As for cash flow statements as of 31st March 2020 and 31st December 2019, the net cash flow increases 461.18 million THB or 92% as a result of the

0.64 : 1 to 0.91 : 1 as of 31 December 2018 and 30 September 2019 respectively. The above ratios do not exceed 1:1 which complies with the policy of the Company. Cash flow statement The cash flow

Company Limited as of 31st December 2019 as follows: A. Book value B. Adjusted book value based on market value C. Discounted cash flow method Value of shares of Modern Pharma Company Limited based on

seller by consideration of reasonable value and the rate of return from investment by Discounted Cash Flow Model. The return of investment is approximately 10 percent. The Company expected that after the

Company will have a cash flow return of Baht 200 – 250 million per year. 7. Expected benefits 1. Acquired businesses are similar or support business of the Company. Because the company have invested in the

between the parties, with reference to valuation of share price by discounted cash flow method.   - 16 - 7. Expected benefits 1. Acquired businesses are similar or support business of the Company. Because

. Liquidity In 2019, the Company had a net decrease of cash and cash equivalents of 375.5 million Baht, divided into cash flow details for each activity as follows: 2018 2019 Cash flow from operating activities

would like to notify that we do not have any cash flow or financial status problem. The Company issued new debenture No.1/2018 amount of 1,075 million baht with 3 years maturity with interest rate 4.3

management; 7.2 resulting in generating cash flow for the Company and supporting the demand for cash flow of the Company in a timely manner without having to bear high operating costs in each month; The

Electronics PCL has the pleasure of reporting the operating results of the Company and its subsidiaries ("the Group") for fiscal year 2018 based on the audited consolidated financial statements for the period